You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Liposomal Grb-2 treatment of CML, AML, CLL, MDS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML) Trial in United States (BP1001 in combination with Ventoclax plus decitabine, BP1001 plus

Recruiting
  • Acute Myeloid Leukemia (AML)
  • BP1001 in combination with Ventoclax plus decitabine
  • BP1001 plus decitabine
  • Fairway, Kansas
  • +5 more
Jan 3, 2022

Recurrent Adult Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001, BP1001

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • +3 more
  • BP1001
  • BP1001 in combination with LDAC
  • Houston, Texas
    M. D. Anderson Cancer Center
May 26, 2020

Chronic Myelogenous Leukemia, Ph1-Positive, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001 (varying

Withdrawn
  • Chronic Myelogenous Leukemia, Ph1-Positive
  • +2 more
  • BP1001 (varying dose)
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
May 26, 2020

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Clofarabine 40mg/m^2
  • +5 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 3, 2020

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

MDS, AML Trial in Austria, Germany (CPX-351, Daunorubicin, Cytarabine)

Recruiting
  • MDS
  • AML
  • Linz, Austria
  • +26 more
Sep 9, 2022

Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • +2 more
  • WT1:126-134
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021

Gas Station Workers

Not yet recruiting
  • Hematologic Diseases
    • (no location specified)
    Nov 13, 2021

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Hyperbaric oxygen
    • Rochester, New York
      Wilmot Cancer Institute, University of Rochester
    May 16, 2022

    Acute Myeloid Leukemia, MDS Trial in United States (CG-806)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Duarte, California
    • +9 more
    Mar 4, 2022

    Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan

    Active, not recruiting
    • Myeloid Malignancies
    • +4 more
    • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
    • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Feb 25, 2022

    Myeloid Leukemia, MDS Trial (IFN-?)

    Not yet recruiting
    • Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Nov 15, 2023

    Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

    Active, not recruiting
    • Hematological Malignancies
    • Duarte, California
    • +26 more
    Dec 7, 2022

    Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

    Withdrawn
    • Drug/Agent Toxicity by Tissue/Organ
    • +3 more
    • amifostine trihydrate
    • +2 more
    • Chicago, Illinois
    • +3 more
    Jan 31, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

    Not yet recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Aug 31, 2023

    Leukemia, Myelodysplastic Syndrome(MDS) Trial in Duarte, Houston (fadraciclib)

    Recruiting
    • Leukemia
    • Myelodysplastic Syndrome(MDS)
    • Duarte, California
    • +1 more
    Apr 1, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Miltenyi CliniMACS Prodigy ® system
    • (no location specified)
    Mar 23, 2023

    Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

    Recruiting
    • Myeloid Malignancies
    • +3 more
    • Houston, Texas
      M D Anderson Caner Center
    Nov 17, 2022

    AML, MDS Trial in Tianjin (XZB-0004)

    Not yet recruiting
    • AML
    • MDS
    • Tianjin, Tianjin, China
      Hematology Hospital, Chinese Academy of Medical Sciences
    Feb 13, 2023

    Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Cytokine Induced Memory-like Natural Killer Cells
    • Interleukin-2
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    iN the Real Practice

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Vyxeos liposomal
    • Roma, Italy
      Policlinico Tor Vergata
    Nov 16, 2023

    Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

    Recruiting
    • Cancer
    • +4 more
    • INKmune
    • Athens, Attiki, Greece
    • +2 more
    Jul 3, 2023

    Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • CIML NK
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Jan 6, 2023